| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. | Principal Accounting Officer | Stock Option (Right to Buy) | 9,450 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | 09 Mar 2026 | 1 | $0 | 4 | Principal Accounting Officer | 11 Mar 2026, 16:14 |
| ALGS | Aligos Therapeutics, Inc. | 29 Jan 2026 | 0 | $0 | 3 | Principal Accounting Officer | 19 Feb 2026, 17:54 |